COMPOSITIONS AND METHODS FOR TREATING EGFR POSITIVE CANCERS

The disclosure provides immune cells comprising a first activator receptor and a second inhibitory receptor, and methods of making and using same for the treatment of cancer. La divulgación proporciona células inmunitarias que comprenden un primer receptor activador y un segundo receptor inhibidor,...

Full description

Saved in:
Bibliographic Details
Main Authors KAMB Carl Alexander, XU Han, OH Julyun
Format Patent
LanguageEnglish
Spanish
Published 10.07.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The disclosure provides immune cells comprising a first activator receptor and a second inhibitory receptor, and methods of making and using same for the treatment of cancer. La divulgación proporciona células inmunitarias que comprenden un primer receptor activador y un segundo receptor inhibidor, y métodos de fabricación y uso de las mismas para el tratamiento del cáncer.
Bibliography:Application Number: MX20230002104